DOJ Reports $3.7B Haul in FY 2017 FCA Recoveries
Client Alert | 1 min read | 12.26.17
On December 21, 2017, the Department of Justice reported that it recovered more than $3.7 billion in settlements and judgments from civil False Claims Act (FCA) cases in Fiscal Year 2017. The FY 2017 recovery is the fourth largest total in thirty years. At the industry level, DOJ reported $2.47B in recoveries from the health care sector, $220M from defense companies, and approximately $1B from the remaining industries such as banking, higher education, and energy.
The change in presidential administration appears to have had little effect on FCA activity. The number of new FCA actions in FY 2017 remained high with relators bringing 674 new qui tam matters and DOJ initiating 125 matters on its own. These numbers are consistent with the prior five years and suggests that FCA will remain an active area for investigations and litigation in 2018.
Contacts
Insights
Client Alert | 4 min read | 04.08.26
Cosmetics Under the Microscope: FDA’s Expanding Regulatory Reach Under MoCRA
The Modernization of Cosmetics Regulation Act of 2022 (MoCRA) marked the most significant expansion of FDA’s authority over cosmetics in 80 years — and the agency is putting that authority to work. From the launch of a new adverse event reporting tool to forthcoming rules on fragrance allergens and good manufacturing practices (GMP), FDA is reshaping the regulatory landscape for manufacturers, packers, and distributors of cosmetic and personal care products.
Client Alert | 11 min read | 04.08.26
Client Alert | 3 min read | 04.07.26
Answering the Top Seven Questions About Pending Section 301 Deadlines
Client Alert | 3 min read | 04.07.26
EU Pharma Package: Fiscal Imports in the Supply Chain Compromise Proposal
